The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
By M. Hamaguchi, T. Kojima, N. Takeda, Takayuki Nakagawa, H. Taniguchi, K. Fujii, T. Omatsu, T. Nakajima, H. Sarui, M. Shimazaki and 3 more. Annals of Internal Medicine, 2006
599 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/b3fff745a225783fa2a6243599533076fb1181e5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Epidemiology
- Z. Younossi
- A. Okunade
- B. Patterson
- A. Baranova
- S. Klein
- Claude B. Sirlin
- G. Vernon
- Gerald I. Shulman
In Pathology and Forensic Medicine
Citations in the corpus
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (2011, background): “reported follow-up data on 3147 individuals without NAFLD at baseline; of these, 308 (10%) developed new cases of NAFLD over 414 days.(3) A recent study of an out-patient hepatology clinic in England reported an incidence rate of 29 cases per 100,000 person-years.”
- Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training (2013, unknown): “(649) reported that insulin resistance was associated with chronic liver disease, especially hepatitis C and nonalcoholic fatty liver disease (449), and MS predicts hepatic steatosis (252).”
- Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. (2019, background): “4 INTRODUCTION Nonalcoholic fatty liver disease (NAFLD) is a common complication of obesity, and is associated with multi-organ insulin-resistance (1, 2), dyslipidemia (high plasma triglyceride and low HDL-cholesterol concentrations) (3, 4), and an increased risk of diabetes and coronary heart disea”